Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria.
about
Cognitive Reserve and the Prevention of Dementia: the Role of Physical and Cognitive ActivitiesAgeing, neurodegeneration and brain rejuvenationCerebrospinal Fluid Biomarkers for Alzheimer's Disease: A View of the Regulatory Science Qualification Landscape from the Coalition Against Major Diseases CSF Biomarker TeamAssociations of cumulative Pb exposure and longitudinal changes in Mini-Mental Status Exam scores, global cognition and domains of cognition: the VA Normative Aging StudyDirect and indirect cost of managing alzheimer's disease and related dementias in the United States.A Precision Medicine Initiative for Alzheimer's disease: the road ahead to biomarker-guided integrative disease modeling.Magnetic resonance imaging and positron emission tomography in the diagnosis of neurodegenerative dementias.Neuropsychiatric symptoms predict hypometabolism in preclinical Alzheimer diseaseDomains of cognitive function in early old age: which ones are predicted by pre-retirement psychosocial work characteristics?Chronic intermittent hypoxia induces oxidative stress and inflammation in brain regions associated with early-stage neurodegeneration.Quantification of Butyrylcholinesterase Activity as a Sensitive and Specific Biomarker of Alzheimer's Disease.Early diagnosis of mild cognitive impairment and Alzheimer's disease based on salivary lactoferrinSerum Amino Acid Profiles in Normal Subjects and in Patients with or at Risk of Alzheimer DementiaTau PET imaging: present and future directions.Early Prediction of Alzheimer's Disease Using Null Longitudinal Model-Based Classifiers.Acute exercise does not modify brain activity and memory performance in APP/PS1 mice.Atrophy of amygdala and abnormal memory-related alpha oscillations over posterior cingulate predict conversion to Alzheimer's diseasePittsburgh compound B imaging and cerebrospinal fluid amyloid-β in a multicentre European memory clinic study.Oleuropein Prevents Neuronal Death, Mitigates Mitochondrial Superoxide Production and Modulates Autophagy in a Dopaminergic Cellular Model.Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease.COMPASS: A computational model to predict changes in MMSE scores 24-months after initial assessment of Alzheimer's diseaseCan Creutzfeldt-Jakob disease unravel the mysteries of Alzheimer?Cognitive Intervention As an Early Non-pharmacological Strategy in Alzheimer's Disease: A Translational Perspective.Qualitative and quantitative assessment of self-reported cognitive difficulties in nondemented elders: Association with medical help seeking, cognitive deficits, and β-amyloid imaging.Interaction between personality traits and cerebrospinal fluid biomarkers of Alzheimer's disease pathology modulates cognitive performance.Cognitive impairment and decline in cognitively normal older adults with high amyloid-β: A meta-analysis.Alzheimer's biomarkers in daily practice (ABIDE) project: Rationale and designNeuroanatomical and Neuropsychological Markers of Amnestic MCI: A Three-Year Longitudinal Study in Individuals Unaware of Cognitive Decline.Visualization of neuritic plaques in Alzheimer's disease by polarization-sensitive optical coherence microscopy.Identifying memory impairment and early dementia in primary care.PRECISION MEDICINE - The Golden Gate for Detection, Treatment and Prevention of Alzheimer's Disease.Profile of 6 microRNA in blood plasma distinguish early stage Alzheimer's disease patients from non-demented subjects.Outcomes Assessment in Clinical Trials of Alzheimer's Disease and its Precursors: Readying for Short-term and Long-term Clinical Trial Needs.Memory performance-related dynamic brain connectivity indicates pathological burden and genetic risk for Alzheimer's disease.Relationship between Cognitive and Sleep-wake Variables in Asymptomatic Offspring of Patients with Late-onset Alzheimer's DiseaseSemantic memory and depressive symptoms in patients with subjective cognitive decline, mild cognitive impairment, and Alzheimer's disease.Biomarker clusters are differentially associated with longitudinal cognitive decline in late midlifeREST, a master regulator of neurogenesis, evolved under strong positive selection in humans and in non human primates.Is use of the internet in midlife associated with lower dementia incidence? Results from the English Longitudinal Study of Ageing.Early functional network alterations in asymptomatic elders at risk for Alzheimer's disease
P2860
Q26740159-62200568-343E-4D31-8063-4DDAFD728BEAQ28071590-AB0E2A76-1B45-4072-9B93-8A87C84F74A9Q28595520-B403CC75-7E12-4492-A314-63557BC16FAAQ29960467-03567D39-E76D-4007-ADB9-702D06CDE907Q30235057-B1B7AC70-543E-4FB6-8A4D-DF9FB4D65895Q30235315-8E96D7B4-049C-423E-B810-BA07AA58A858Q31153910-D6127913-DE0A-45A5-B61A-E18CF34FF0A4Q33644324-E3D6B801-CD4E-44EB-BAB0-6FC0C5E41B9AQ33676461-216ABE69-8E5F-4A14-B93E-B9AE6BAA4A5AQ33679761-D991827F-E87A-4C58-95C0-FDC26E6CA010Q33708963-A10A8B10-AF63-4F78-8BEF-93A5FD2AF909Q33797110-3B208F53-A2C0-4D6B-84D9-46E6C3301510Q33801596-34437D3C-B126-4338-B23E-77BC8FE48527Q34680852-E4661C49-9AFD-442B-8BD4-D69C76DCAF7EQ36237796-FCA4AF04-DAAE-4C29-A796-E6E017F327F1Q36380530-2059AFA3-0E39-4AF4-8660-E605C42AA78EQ37193075-D68663C4-4EF4-4FC3-A2F8-102AEF28BB11Q37198556-26499EB7-B4EB-4F3C-9BCB-6649844CC803Q37210083-EB2C3D4B-213F-4414-8589-AE7DEB35145CQ37307467-FDC81C1C-24A7-4AA5-958B-C41CB8914A1BQ37310868-67BFF520-9961-43C5-B22E-F84B7C33FFAEQ37409402-383E39C7-2CF1-4892-AFD5-AA58D768C67FQ37450115-AF74004C-29BD-47EF-B42E-9C252A2D1E0AQ37544208-428026F3-C23C-401E-A4C5-B635000B646EQ37622965-6B30AF9D-53D1-406F-89B8-BDFD1AC5132BQ37650253-E7E7E1F2-233E-40D4-90C3-862635A53B60Q37654117-E6ECC338-778A-4D92-99B9-AE31BD1801E1Q37657965-901E223F-7A34-4EC9-BBB2-3E3BF63FE4C1Q37681751-EA95757F-9518-4618-A787-9D5BC13DA5B8Q37682700-B63E7A61-6196-46E4-94A1-631B3364C56DQ37718557-94B43139-4AAF-42F1-BD19-9D232DF9B2A3Q37725397-5B5EA204-E1E4-4E94-A8A0-B01586C3AA8FQ37730520-91BD6FC0-40B7-4D14-A5BE-251D6D559C91Q37731606-56047194-1334-4246-A9CC-3E2987E95904Q37737603-88010D04-110B-49C7-BD90-2E28425BBACEQ38378577-CC995AAE-2D70-456B-89A2-8B53A0ED4B22Q38391075-883C053D-3123-4C04-BE6D-DACAEE8A3545Q38607601-79D41BAA-E47C-45CD-8D30-8210223F9B21Q38631002-AC553641-BE46-4D37-9FAF-C5D02370A95FQ38659127-155D4839-4E7C-4D67-92B8-5B17B7150EC0
P2860
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria.
description
2016 nî lūn-bûn
@nan
2016 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մարտին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria.
@ast
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria.
@en
type
label
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria.
@ast
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria.
@en
prefLabel
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria.
@ast
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria.
@en
P2093
P50
P1476
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
@en
P2093
Alida A Gouw
Bruno Dubois
Charles Duyckaerts
Christopher Rowe
Cliff R Jack
David M Holtzman
Enrica Cavedo
Gil D Rabinovici
Habib Benali
Harald Hampel
P304
P356
10.1016/J.JALZ.2016.02.002
P50
P577
2016-03-01T00:00:00Z